CTOs on the Move

Spenco Medical Corporation

www.spenco.com

 
"Cutting Edge medical is owned and operated by an authorized distributer for SPENCO located in Central New York , NY . SPENCO Medical Corporation was incorperated in 1967 with one goal - "" to provide customers with unique, marketable products and"
  • Number of Employees: 250-1000
  • Annual Revenue: $10-50 Million
  • www.spenco.com
  • 6301 Imperial Dr
    Waco, TX USA 76712
  • Phone: 254.772.6000

Executives

Name Title Contact Details

Similar Companies

lensgen

LensGen™ is an ophthalmic medical device company developing an accommodating intraocular lens (AIOL) based solution to treat presbyopia and/or cataracts.

Alliance Medical Services

Alliance Medical Services is a Holland, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

OrthoGrid Systems

OrthoGrid Systems is a rapidly expanding global leader in orthopedic imaging technology with specialized applications available or in development for hip arthroplasty, trauma, knee replacement, and other common procedures performed over 1 million times per year in aggregate in the USA and 3 million times globally. OrthoGrid helps to overcome the limitations of traditional low resolution, distorted imaging technology by providing computerized image correction and image guidance direction to physicians performing orthopedic procedures.

Conquest Imaging

Conquest Imaging is your one-stop source for all your diagnostic ultrasound needs. We provide the highest quality parts, probes, transducer repair, on-site service, technical training, reconditioned systems and free, 24x7x365 technical support.

JenaValve

JenaValve Technology, Inc., based in Irvine, California and Munich, Germany develops, manufactures and markets transcatheter aortic valve implantation (TAVI) systems to treat patients suffering from aortic valve disease. The Company’s transapical TAVI system is CE marked and currently marketed in Europe and other markets worldwide and its new transfemoral TAVI system is currently undergoing clinical evaluation in Europe with a view toward achieving CE Mark in 2015. JenaValve is backed by world-class U.S., European and Asian investors, including Atlas Venture, Edmond de Rothschild Investment Partners, GIMV, NeoMed Management, Legend Capital, VI Partners, Sunstone Capital, Omega Funds, Biovest and Valiance Advisors.